With the Capitol divided, the Trump administration is expected to focus on forging an infrastructure deal with Congress and potentially working to rein in drug prices — two policy areas typically more aligned with liberals, according to interviews with six current and former administration officials and Republicans close to the White House.

“If there is anything bipartisan, it’s lowering drug prices,” Trump said at a White House bill-signing ceremony last month.

Expectations that the two sides could work out a major deal on something like negotiating drug prices in Medicare are low — but there is hope in both parties that impactful incremental reforms, like increasing transparency around drugmakers’ relationships with pharmacy benefit managers to ensure there is no collusion to keep prices high, could get bipartisan support.